Juan Enrique Bargallo Rocha
Overview
Explore the profile of Juan Enrique Bargallo Rocha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hyams D, Bareket-Samish A, Rocha J, Diaz-Botero S, Franco S, Gagliato D, et al.
J Surg Oncol
. 2024 Jun;
130(2):166-187.
PMID: 38932668
Gene expression assays (GEAs) can guide treatment for early-stage breast cancer. Several large prospective randomized clinical trials, and numerous additional studies, now provide new information for selecting an appropriate GEA....
2.
Shveid Gerson D, Gerson-Cwilich R, Lara Torres C, Chousleb de Kalach A, Ventura Gallegos J, Badillo-Garcia L, et al.
Front Oncol
. 2023 Jan;
12:988968.
PMID: 36591465
Introduction: Obesity has been associated with an increased risk of biologically aggressive variants in breast cancer. Women with obesity often have tumors diagnosed at later stages of the disease, associated...
3.
Aapro M, De Laurentiis M, Rea D, Rocha J, Elizalde R, Landherr L, et al.
Breast
. 2017 Apr;
33:191-199.
PMID: 28441617
Background: A modest proportion of patients with early stage hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer benefit from adjuvant chemotherapy. Traditionally, treatment recommendations are based on clinical/pathologic criteria that are...
4.
Hyams D, Schuur E, Angel Aristizabal J, Rocha J, Cabello C, Elizalde R, et al.
J Surg Oncol
. 2017 Feb;
115(6):647-662.
PMID: 28211064
Risk stratification of patients with early stage breast cancer may support adjuvant chemotherapy decision-making. This review details the development and validation of six multi-gene classifiers, each of which claims to...